Zafgen, Inc. ZFGN saw a big move in the last trading session, as the company’s shares fell by nearly 36% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent trend for ZFGN, as the stock is now down over 44% in the past one-month time frame.
The biopharmaceutical company, which focuses on the development of therapeutics for patients suffering from obesity and obesity-related disorders, has seen a flat track record when it comes to current year estimate revisions over the past few weeks, and the consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
ZFGN currently holds a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors interested in the Medical — Drugs industry may consider a better-ranked stock like Lannett Company, Inc. LCI, carrying a Zacks Rank #1 (Strong Buy).
Is ZFGN going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment